NCT06619002 Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies Status RECRUITING Phase N/A
NCT06614751 A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway Status NOT_YET_RECRUITING Phase PHASE1
NCT06613230 Improved Early Diagnosis in Female Pelvic Cancer With OC Detect Status COMPLETED Phase N/A
NCT06603506 Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study Status RECRUITING Phase N/A
NCT06598085 Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery Status ACTIVE_NOT_RECRUITING Phase NA
NCT06584630 Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06552598 The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies Status RECRUITING Phase PHASE1
NCT06549855 PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer Status NOT_YET_RECRUITING Phase NA
NCT06548763 Oral Topotecan With Toripalimab for Patients With Endometrial Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06547840 A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha Status RECRUITING Phase PHASE1
NCT06538337 Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers Status RECRUITING Phase NA
NCT06533059 A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06531486 A Study of XS-02 Capsules in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06515613 A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06502743 First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer Status RECRUITING Phase PHASE2
NCT06501846 Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding. Status RECRUITING Phase NA